The AZ&Me Prescription Savings program is making medicines more affordable for Medicare Part D beneficiaries. The program, created by AstraZeneca, is the first to provide savings right at the pharmacy counter. To qualify for AZ&Me, which has no enrollment fee, an individual must meet the following criteria:
Patients will have the option of receiving a 60- or 90-day refill with a physician's prescription if they complete the application documentation and submit proof of their year-to-date out-of-pocket prescription drug expenses. The program has a flat patient fee of either $15 or $25 for a typical 30-day script.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs